about
The ligurian human immunodeficiency virus clinical network: a web tool to manage patients with human immunodeficiency virus in primary care and multicenter clinical trials.Generation of more effective cancer vaccinesSmall intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis.CD8+ T suppressor cells are back to the game: are they players in autoimmunity?Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one.Non-antigen specific CD8+ T suppressor lymphocytes.Disruption of immunological tolerance: role of AIRE gene in autoimmunity.Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.Gene vaccination for the induction of immune tolerance.Modulation of p38 MAPK activity in regulatory T cells after tolerance with anti-DNA Ig peptide in (NZB x NZW)F1 lupus mice.CD8(+) T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity.Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases.Nanoparticles increase the efficacy of cancer chemopreventive agents in cells exposed to cigarette smoke condensate.Efficacy of cilostazol for the treatment of Raynaud's phenomenon in systemic sclerosis patients.Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer.Spontaneous transgenesis of human B lymphocytes.Increased CD38 expression on T lymphocytes as a marker of HIV dissemination into the central nervous system.Fingolimod modulates peripheral effector and regulatory T cells in MS patients.Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence.Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunity.Blunted coronary flow reserve in systemic sclerosis: a sign of cardiac involvement in asymptomatic patients.Major histocompatibility complex class I-restricted presentation of influenza virus nucleoprotein peptide by B lymphoma cells harboring an antibody gene antigenized with the virus peptide.Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis.A case of successful pregnancy in a woman with systemic sclerosis treated with cyclosporin.Cyclophosphamide inhibits the generation and function of CD8(+) regulatory T cells.Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells.Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation.Immune cell circulating subsets are affected by gonadal function.Increased beta2-microglobulin-free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens.Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer.Adipokines and sublingual immunotherapy: preliminary report.Serum leptin levels in patients with pollen-induced allergic rhinitis.Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patients.AIRE gene polymorphisms in systemic sclerosis associated with autoimmune thyroiditis.B cells characterization in ADA2 Deficiency patients.Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patientsBioactive surfaces for antibody-antigen complex detection by Atomic Force Microscopy
P50
Q33855379-7CFB1F80-AD5A-45FD-8A06-DCE09DEFBCEEQ34169981-CEA09428-7175-4762-B185-6BC8F40D5B12Q34590794-1BC6B19C-3BDC-4C44-8040-352A460C5611Q35148923-4467B2B5-CA27-476B-8779-87945BE9E8ACQ35172060-63664864-80D2-47EA-90D3-7FC41EE8D721Q35886889-038B5010-031C-4F02-AB29-CB537EFAD47FQ36021094-B6D2FB90-6110-4803-9E61-955FE6810E6EQ36375744-4204E9A3-82E7-4ADD-83AD-E7EFA7C645F4Q36604614-0234F7A6-13D7-45CC-8C60-3385B1706DD6Q36958305-E19F5687-6108-43EA-8DEA-B7E1E9E61AA9Q37379313-8102BC35-9587-4379-B2FF-FA374E432F6CQ37776500-5230E856-4BD7-40D6-B2D9-4B84D60F76D3Q38013540-0AF7757E-9FDC-4478-B51B-835951DCA696Q38912777-4011AD12-3E0F-4572-8B66-D57D149E56B7Q40289594-15882A34-82EF-42F2-8F36-C2C953AC804EQ40357992-2599FEBF-0931-43E5-99E5-79DB5220D549Q40606303-2F9C728E-3A1D-4E6C-9CBB-D8760A09C722Q41002594-199A3FCD-4588-4552-BF65-265E1F8B797AQ41867086-A94A472C-08D7-4B7E-9981-3FA21E29918BQ42084378-2AD952CD-E69F-46CC-8D3B-1BD4CEBB3F20Q42649288-1DA2C8F8-0BDE-4D58-A00B-11B8E8C5F7A8Q42712738-331D6000-DE26-464D-A9F4-733E48790FDCQ43826240-4907F49A-79AB-400D-AABA-5E54FBDFC5FEQ44939473-EC64CD75-CCEC-4D00-8A31-DDD249EACC60Q45078099-DE0DE746-283E-412A-865E-55AAEE46F3DBQ46058925-5C8359A6-7B11-4D04-9DCB-72076FFA8698Q46334448-619056FE-C48A-43D8-9730-A6EEDCCCDAB9Q46435048-75DE7992-D5D7-4853-B0BA-F5E8BB5422E6Q46598497-82D21BBF-B3D7-4D16-9818-47FAA2737F6BQ48201151-8CFCB2EE-C061-4CBE-9727-B6ABCFDDAAC0Q50586828-E7469BFE-AA46-463B-BD8F-A446EA304228Q51032192-6BD4BE92-344D-4106-B3DD-F75001881B8FQ51065162-F1E95C87-D924-45BC-857E-18894F37DD3BQ51672811-1D7C022D-83A3-4713-AB5F-67CD79D1733AQ51679265-69C5EAD4-F4FF-45B7-AED0-34872086C208Q51834455-CF963E43-D0F0-485E-865D-D93D2C573524Q54571710-86421E05-DFBE-434F-BB11-681292A1539AQ55121614-599E8515-B8EE-40BC-AFA3-166DE0BA00CCQ58051212-95D97D2C-01B8-4611-B4F1-331671E7475DQ60182423-434E2983-9F13-45AB-9F23-99EEC9CF5355
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gilberto Filaci
@ast
Gilberto Filaci
@en
Gilberto Filaci
@es
Gilberto Filaci
@nl
Gilberto Filaci
@sl
type
label
Gilberto Filaci
@ast
Gilberto Filaci
@en
Gilberto Filaci
@es
Gilberto Filaci
@nl
Gilberto Filaci
@sl
prefLabel
Gilberto Filaci
@ast
Gilberto Filaci
@en
Gilberto Filaci
@es
Gilberto Filaci
@nl
Gilberto Filaci
@sl
P1053
K-5062-2016
P106
P1153
7004256757
P21
P31
P3829
P496
0000-0001-6445-8414